Donors and staff are required to wear masks or reasonable cloth-based face coverings. If you’ve been vaccinated against COVID-19, you may still donate blood or platelets. Read our COVID-19 FAQs.

Welcome, Donor!

COVID patients need your help.

JOIN THE COVID RESCUE TEAM
COVID-19 patients desperately need your plasma.
JOIN THE COVID RESCUE TEAM
COVID-19 patients desperately need your plasma.

JOIN THE COVID RESCUE TEAM



Your Donation May Help Patients Battling COVID-19

Are you fully recovered from COVID-19, or suspect you may have had COVID-19 but weren’t tested – and have been symptom free at least 14 days?

If so, your blood or platelet donation could help COVID-19 patients. We’re testing all donations for COVID-19 antibodies. If your donation is antibody positive, we can produce convalescent plasma from it to help COVID-19 patients–and the remaining blood components will help other patients with serious medical conditions.

Important notes:

SCHEDULE YOUR APPOINTMENT TODAY

Schedule your blood or platelet donation appointment online today or call 1-877-258-4825.

Schedule Now

Questions? Email us at covidfree@vitalant.org.

donor and tech

COVID Plasma as a Therapeutic

The Food and Drug Administration is allowing the transfusion of convalescent plasma as an investigational treatment. Vitalant is working with hospitals to collect, process and distribute the plasma to help patients with active, serious COVID-19 infections.

Additionally, Vitalant Research Institute is developing technologies to detect and quantify virus-fighting antibodies to COVID-19.

Patients or Family Members Seeking Convalescent Plasma

Vitalant does not provide convalescent plasma directly to individuals. Please contact your clinician to explore the potential for receiving this treatment.

*COVID-19 convalescent plasma has not been approved or licensed by the FDA; COVID-19 convalescent plasma has been authorized by the FDA under an emergency use authorization (EUA); COVID-19 convalescent plasma is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.